LUPI offers to its customers a complete range of development and production services for current Good Manufacturing Practices (cGMP) advanced intermediates and Active Pharmaceutical Ingredients (API), from route screening to process development and optimization, industrialization and large scale commercial production.
Business model
A flexible, effective and competitive business
LUPI’s business model is built on three different lines of products, ensuring a great flexibility in the production planning and optimal capacity utilization, providing for high equipment occupancy and effective costs management.
Three areas, one business model
LUPI has three lines of products:
LUPI has a long tradition as manufacturer of APIs for the generics market. Thanks to both its knowledge and expertise in process chemistry, Intellectual Property Rights (IPR) and regulatory affairs and its professional team, LUPI adds to its pipeline an average of 2-3 molecules per year.
LUPI is a decisive player in H. Lundbeck A/S supply chain as a source of APIs and intermediates for both clinical trials and for commercial products.
